(Q38110002)

English

Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer .

scientific article published on January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer . (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

based on heuristic

inferred from title

author name string

Dimitrios Zardavas

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

David Cameron

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Ian Krop

3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Martine Piccart

4

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

American Society of Clinical Oncology educational book / ASCO

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Identifiers

10.1200/EDBOOK_AM.2013.33.E2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38110002&oldid=2097193893"